Recent News

• 10.02.2025 - XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
• 10.02.2025 - XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
• 09.30.2025 - LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025
• 09.30.2025 - LAVA Therapeutics to Move Extraordinary General Meeting to Early November 2025

Recent Filings

• 09.30.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 09.30.2025 - EX-99.1 EX-99.1
• 09.30.2025 - 8-K Current report
• 09.26.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 09.23.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.23.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 09.18.2025 - SCHEDULE 13D/A General Statement of Acquisition of Beneficial Ownership
• 09.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.09.2025 - SC TO-T/A Tender offer statement by Third Party
• 09.03.2025 - DEFM14A Definitive proxy statement relating to merger or acquisition